These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348 [TBL] [Abstract][Full Text] [Related]
4. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511 [TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria]. Aronova NV; Pavlovich NV Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797 [TBL] [Abstract][Full Text] [Related]
6. Proteome cataloging and relative quantification of Francisella tularensis tularensis strain Schu4 in 2D PAGE using preparative isoelectric focusing. Waldo RH; Cummings ED; Sarva ST; Brown JM; Lauriano CM; Rose LA; Belland RJ; Klose KE; Hilliard GM J Proteome Res; 2007 Sep; 6(9):3484-90. PubMed ID: 17658781 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Green M; Choules G; Rogers D; Titball RW Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452 [TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173 [TBL] [Abstract][Full Text] [Related]
9. Nature of protective immunity to Francisella tularensis. Tärnvik A Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002 [TBL] [Abstract][Full Text] [Related]
10. Comparative proteome analysis of fractions enriched for membrane-associated proteins from Francisella tularensis subsp. tularensis and F. tularensis subsp. holarctica strains. Pavkova I; Reichelova M; Larsson P; Hubalek M; Vackova J; Forsberg A; Stulik J J Proteome Res; 2006 Nov; 5(11):3125-34. PubMed ID: 17081064 [TBL] [Abstract][Full Text] [Related]
11. iTRAQ quantitative analysis of Francisella tularensis ssp. holarctica live vaccine strain and Francisella tularensis ssp. tularensis SCHU S4 response to different temperatures and stationary phases of growth. Lenco J; Link M; Tambor V; Zaková J; Cerveny L; Stulik AJ Proteomics; 2009 May; 9(10):2875-82. PubMed ID: 19415661 [TBL] [Abstract][Full Text] [Related]
12. Immunological markers that correlate with protection immunity against tularemia infection. Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607 [TBL] [Abstract][Full Text] [Related]
13. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. Cowley SC; Hamilton E; Frelinger JA; Su J; Forman J; Elkins KL J Exp Med; 2005 Jul; 202(2):309-19. PubMed ID: 16027239 [TBL] [Abstract][Full Text] [Related]
14. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays. Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360 [TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of an attenuated Francisella tularensis dsbA mutant: identification of potential DsbA substrate proteins. Straskova A; Pavkova I; Link M; Forslund AL; Kuoppa K; Noppa L; Kroca M; Fucikova A; Klimentova J; Krocova Z; Forsberg A; Stulik J J Proteome Res; 2009 Nov; 8(11):5336-46. PubMed ID: 19799467 [TBL] [Abstract][Full Text] [Related]
16. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. Tärnvik A; Ericsson M; Golovliov I; Sandström G; Sjöstedt A FEMS Immunol Med Microbiol; 1996 Mar; 13(3):221-5. PubMed ID: 8861033 [TBL] [Abstract][Full Text] [Related]
17. The heat-shock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice. Meibom KL; Dubail I; Dupuis M; Barel M; Lenco J; Stulik J; Golovliov I; Sjöstedt A; Charbit A Mol Microbiol; 2008 Mar; 67(6):1384-401. PubMed ID: 18284578 [TBL] [Abstract][Full Text] [Related]
18. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711 [TBL] [Abstract][Full Text] [Related]
19. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662 [TBL] [Abstract][Full Text] [Related]
20. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]